News


IXICO webinar session;
Using MRI to assess safety, efficacy and eligibility of new Alzheimer's Disease therapies. This Webinar is now over. “We were overwhelmed with the turnout and level of participation”.Ciaran Cooper. VP Business Development.
A re-run of this session will be announced soon.
For more information  Click here

ISO 9001 Certified

Trial services

IXICO offers comprehensive technology-enabled imaging CRO services to the pharmaceutical and biotech industries across all imaging modalities, therapeutic areas, and clinical trials phases. We have special expertise in MRI, CT, and PET in neurodegenerative diseases, musculoskeletal indications, and oncology.

We provide proprietary tools for image de-identification, transfer, processing, management, and archiving, all under GCP and within the scope of our  ISO9001:2000 certified quality management system. Our technology is proven, validated, and compliant with European patient privacy legislation, HIPAA and 21CFR Part 11 regulations. Our team of imaging experts is dedicated to providing the very best service to ensure your success.

Consultation

  • Protocol review and design
  • Modality selection
  • Acquisition standardization
  • Review criteria evaluation
  • Special analysis review

Study Start-up

  • Site selection and qualification
  • Scanner performance evaluation
    • Including phantom studies
    • Data quality assurance
    • Workflow development
    • Communications Plan development
    • Site Manual development
    • eCRF development
    • Site Training
      • Protocol-specific
      • Modality-specific

Site Management

  • Web-enabled data handling
    • De-identification
    • Electronic transfer
    • Automatic audit trails
    • Protocol compliance monitoring
    • Integrated communications

Project Management

  • Web-enabled communications
    • Real-time data tracking
    • Query alerts and resolution
    • Expert oversight
    • Experienced project managers

Core Lab

  • QC
  • Image Processing
  • Analysis
  • Independent central review

Advanced Analysis

  • New and established algorithms
  • Network of experts

Data Management

  • Secure archival
  • Storage and retrieval
  • Search and query

"Working with our customers, we can unlock imaging's potential to accelerate and reduce the costs of product development, and hence give more patients earlier access to effective and safe treatments."

Prof Derek Hill,
CEO, IXICO

New article

Expert Opinion on Investigational Drugs - by Derek Hill, CEO

The North American Alzheimer's Disease Neuroimaging Initiative, and similar activities in Europe, Japan, and Australia, are natural history studies that are providing new insights into the use of imaging end points in clinical trials. See the article here.